References
- [1] Dey NS, Majumdar S, Rao MEB. Multiparticulate drug delivery systems for controlled release. Trop J Pharm Res. 2008; 7: 1067-1075.10.4314/tjpr.v7i3.14692
- [2] Uros K, Sasa B, Igor L et al. Determining the polymer threshold amount for achieving robust drug release from HPMC and HPC matrix tablets containing a high dose BCS class 1 model drug: in vitro and in vivo studies. AAPS PharmSciTech. 2014; 16: 398-406.
- [3] Jedinger N, Khinast J, Roblegg E et al. The design of controlled release formulations resistant to alcohol induced dose dumping-a review. Eur J Pharm Biopharm. 2014; 87: 217-226.10.1016/j.ejpb.2014.02.008
- [4] Dashevsky A, Koller K, Bodmeier R. Compression of pellets coated with various aqueous polymer dispersions. Int J Pharm. 2004; 279: 19-26.10.1016/j.ijpharm.2004.03.019
- [5] Fukui S, Yano H, Yada S, Mikkaichi T, Minami H. Design and evaluation of an extended release matrix tablet formulation, the combination of Hypromellose acetate succinate and hydroxypropylcellulose. Asian J Pharm Sci. 2017; 12: 149-156.10.1016/j.ajps.2016.11.002
- [6] Rajabi SAR, Farrel TP. Aqueous polymeric coatings for pharmaceutical dosage forms. Eds McGinity J.W. and Feton LA; 2008.
- [7] Bhad ME, Abdul S, Jaiswal SB, Chandewar AV, Jain JM, Sakarkar M. Int J PharmTechRes. 2010; 2: 847-855.10.1016/j.jconrel.2010.05.014
- [8] Vetchý D, Kopecká M, Vetchá M, Franc A. Modely in vitro-in vivo vo vývoji liečiv. Chem Listy. 2014; 108: 32-39.
- [9] Al-Hashimi N, Begg N, Alany RG, Hassanin H, Elshaer A. Oral modified release multiple unit particulate systems: Compressed pellets, microparticles and nanoparticles. Pharmaceutics. 2018; 10 (1-23).10.3390/pharmaceutics10040176
- [10] Siepmann J., Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Delivery Rev. 2001; 48: 139-157.10.1016/S0169-409X(01)00112-0